Examples of potential mHLA-DR-directed interventions that could find utility in AP and COVID-19 include several immunostimulatory agents, including IFN-γ [155,182,183,184], recombinant IL-7 [185], and granulocyte-macrophage colony-stimulating factor [155]. The gene discussed is CSF2; the disease is COVID-19.